An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection
- 17 September 1999
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 23 (10) , 921-929
- https://doi.org/10.1016/s0145-2126(99)00110-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Low rate of somatic hypermutations characterize progressive B-cell lymphomas.European Journal of Haematology, 2009
- Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia.Journal of Clinical Oncology, 1998
- Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphomaBone Marrow Transplantation, 1998
- Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genesLeukemia, 1997
- Assessment of Clonality in Cutaneous Lymphoid Infiltrates by Polymerase Chain Reaction Analysis of Immunoglobulin Heavy Chain Gene RearrangementAmerican Journal of Clinical Pathology, 1997
- The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALLBritish Journal of Haematology, 1996
- Minimal Residual Disease in Acute Lymphoblastic Leukaemia—PCR Analysis of Immunoglobulin Gene RearrangementsLeukemia & Lymphoma, 1993
- Antigen receptor genes as molecular markers of lymphoid neoplasms.Journal of Clinical Investigation, 1987
- Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas.The Journal of Experimental Medicine, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985